Clinical Trial

A Study to Investigate the Biomarkers of Hemay005 in Adult Participants With Moderate to Severe COPD

Name: A Study to Investigate the Biomarkers of Hemay005 in Adult Participants With Moderate to Severe COPD — clinical trial record (NCT07314242)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

A Multicenter, Randomized, Double-blind, Single-dummy, positive drug and placebo-controlled, Parallel Group, Phase 2a Study to Evaluate the Efficacy and Safety of Hemay005 in Adults with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).

Trial Details

NCT Number	NCT07314242
Lead Sponsor	Ganzhou Hemay Pharmaceutical Co., Ltd
Conditions	COPD (Chronic Obstructive Pulmonary Disease)
Enrollment	120 participants
Start Date	2026-01-01
Primary Completion	2027-12-31 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-01-02